![](https://www.pdfsearch.io/img/4c410efda5fbd8d307caba1aa4d539d4.jpg) Date: 2017-11-01 01:14:19
| | FDA Grants Fast Track Designation to Visterra’s VIS410 for Treatment of Hospitalized Patients with Influenza A - Company Plans to Initiate Phase 2b Clinical Trial in Early 2018 Cambridge, MA – November 1, 2017 – ViAdd to Reading ListSource URL: visterrainc.comDownload Document from Source Website File Size: 111,89 KBShare Document on Facebook
|